Navigation Links
BGI Tech develops novel 'Ultra-Deep de novo' assembly solution for heterozygous genomes
Date:3/11/2013

Shenzhen, China, March 11, 2013- BGI Tech Solutions Co., Ltd., also referred to as "BGI Tech", introduced today its novel assembly solution for facilitating heterozygous genomes research. This marks another technological breakthrough for BGI in heterozygous genome assembly after the completed genome sequencing of oyster, diamondback moth and pear.

The availability of a reference genome for a species is the cornerstone for the in-depth understanding of its biological secrets and commercial values. However, a major obstacle that prevents scientists to easily crack the genome of a heterozygous species is the cost-intensive and time-consuming process through traditional assembly approaches.

To overcome the technical difficulties, researchers from BGI Tech developed a novel assembly solution, Ultra-Deep de novo, based upon high-throughput sequencing technology. The new solution adopts BGI's latest assembly software, SOAPdenovo2, and heterozygous sequence processing algorithm. After processing the genomic data produced by ultra-deep sequencing (>200X), the heterozygous regions within the genome can be entirely reserved and classified, with high quality and efficiency.

"Ultra-Deep de novo can serve as a robust tool for researchers to efficiently decode heterozygous genomes." said, Junyi Wang, Senior Vice President of BGI Tech, "BGI has completed the genome sequencing of more than 570 species to date. Some of the species have not been studied because of the challenges posed by high heterozygosis. We believe that this new solution will be a powerful tool for researchers to crack more heterozygous genomes, and boost the further development of agriculture and human health."


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Page: 1

Related biology news :

1. Diabetes Research Institute develops oxygen-generating biomaterial
2. Genetic research develops tools for studying diseases, improving regenerative treatment
3. Pod corn develops leaves in the inflorescences
4. Geneticist develops tool to identify genes important in disease, tailoring individual treatment
5. MindSpec develops Autism Quiz app
6. Pitt develops biodegradable artery graft to enhance bypass surgeries
7. University of Illinois professor develops tool that helps dietitians deliver info clients need and can understand
8. US-Russian collaboration develops new method for sequencing dark matter of life from a single cell
9. MMV develops framework to assess risk of resistance for antimalarial compounds
10. IU chemist develops new synthesis of most useful, yet expensive, antimalarial drug
11. BGI Tech develops whole exome sequencing analysis of FFPE DNA samples to boost biomedicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
Breaking Biology Technology: